PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22659627-12	2012	In contrast, intravenous infusion of the eNOS inhibitor L-NNA (10 mg kg(-1)) completely abrogated the SIM-induced cardioprotection and eNOS phosphorylation during ischemia and reperfusion, but did not affect the activity of PKA.	Simvastatin	102-105	nitric oxide synthase 3	Sus scrofa	41-45	
22659627-10	2012	SIM significantly increased the activities of PKA and constitutive NOS, and increased Ser(133) p-CREB protein, Ser(1179) p-eNOS, and Ser(635) p-eNOS in ischemic myocardium.	Simvastatin	0-3	nitric oxide synthase 3	Sus scrofa	123-127	
22659627-10	2012	SIM significantly increased the activities of PKA and constitutive NOS, and increased Ser(133) p-CREB protein, Ser(1179) p-eNOS, and Ser(635) p-eNOS in ischemic myocardium.	Simvastatin	0-3	nitric oxide synthase 3	Sus scrofa	144-148	
12637638-7	2003	Simvastatin-treated animals showed increased expression of endothelial nitric-oxide-synthase (eNOS), and decreased expression of the ox-LDL receptor LOX-1 in renal endothelial cells.	Simvastatin	0-11	nitric oxide synthase 3	Sus scrofa	59-92	
12637638-7	2003	Simvastatin-treated animals showed increased expression of endothelial nitric-oxide-synthase (eNOS), and decreased expression of the ox-LDL receptor LOX-1 in renal endothelial cells.	Simvastatin	0-11	nitric oxide synthase 3	Sus scrofa	94-98